Drugs / MVA-NP+M1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01465035 | Oct 2011 → Nov 2012 | influenza | University of Oxford | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MVA-NP+M1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01465035 ↗ |
| Modality | Vaccine | “candidate influenza vaccine MVA-NP+M1” NCT01465035 ↗ |
| Route | Intramuscular | “1.5 x 108 pfu MVA-NP+M1, intramuscular injection into the thigh.” NCT01465035 ↗ |